Allurion Technologies, Inc. (ALUR) came out with a quarterly loss of $7 per share versus the Zacks Consensus Estimate of a loss of $5. This compares to loss of $15.75 per share a year ago.

(Operator Instructions) Good morning, and thank you for joining us. Earlier today, Allurion Technologies Inc., Issued a press release announcing financial results for the quarter ended December 31 ...

Good morning, and thank you all for joining us. Earlier today, Allurion Technologies Inc. issued a press release announcing financial results for the quarter ended December 31st, 2024 and provided ...

(Operator Instructions) Good morning, and thank you for joining us. Earlier today, Allurion Technologies Inc., Issued a press release announcing financial results for the quarter ended December 31, ...

NATICK, Mass., April 03, 2025--Allurion Technologies, Inc. ("Allurion" or the "Company") (NYSE: ALUR), a company dedicated to ending obesity, today announced that its Special Meeting of Stockholders ...

Allurion Technologies Inc. (ALUR) reported its Q4 2024 earnings, revealing a notable decline in revenue and gross profit compared to the previous year. Despite these challenges, the company ...

Allurion Technologies Inc. focuses on ending obesity with a weight loss platform to treat people who are overweight. Its platform, the Allurion Program, a swallowable and procedure-less ...

Allurion Technologies Inc focuses on ending obesity with a weight loss platform to treat people who are overweight. Its platform, the Allurion Program, features swallowable and procedure-less ...